Challenges in the management of microscopic polyangiitis: past, present and future
Author:
- 1 January 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 20 (1) , 3-9
Abstract
Microscopic polyangiitis is defined within the context of primary systemic vasculitis. The presentation and management of renal involvement in microscopic polyangiitis is discussed, with emphasis on prognosis and outcomes. Potential roles of newer therapies are reviewed. The histological features of kidney disease in microscopic polyangiitis have been associated with clinical presentation and renal outcome. The predictive value of antineutrophil cytoplasm antibody positivity after induction therapy has been highlighted. Plasma exchange improves renal recovery rates in severe presentations in a randomized trial. Initial results with rituximab have indicated that the B cell is an important therapeutic target in vasculitis and that B-cell depletion has the potential to replace immune suppressive treatment in the future. Microscopic polyangiitis is a subgroup of primary systemic vasculitis, but diagnostic problems remain with antineutrophil cytoplasm antibody-negative cases and in those without kidney disease. Plasma exchange has a confirmed place in therapy. The poor outcomes of many patients indicate safer, more effective therapies are required. Improved biomarkers are needed to assist in drug selection, monitoring and prognosis.Keywords
This publication has 55 references indexed in Scilit:
- Peripheral neuropathy in Wegener's granulomatosis, Churg Strauss syndrome and microscopic polyangiitisJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamideAnnals of the Rheumatic Diseases, 2007
- EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisAnnals of the Rheumatic Diseases, 2007
- Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studiesAnnals of the Rheumatic Diseases, 2007
- Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purificationBMC Genomics, 2007
- Incidence of ANCA-Associated Primary Renal Vasculitis in the Miyazaki PrefectureClinical Journal of the American Society of Nephrology, 2006
- What is new in the therapy of ANCA- associated vasculitides?Take home messages from the 12th workshop on ANCA and systemic vasculitidesClinical Nephrology, 2005
- TNFR1‐ and TNFR2‐mediated signaling pathways in human kidney are cell type‐specific and differentially contribute to renal injuryThe FASEB Journal, 2005
- The clinical and pathological characteristics of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated small vessel vasculitisExperimental Gerontology, 2004
- Über die nur mikroskopisch erkennbare Form der Periarteriitis nodosaVirchows Archiv, 1923